USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
17 - 20 Jun 2024 | Amsterdam

Ghosts in the machine: Empowering healthcare to capitalise on GenAI

Keep exploring for FREE!

Create a free account or log in to unlock content, event past recordings and more!

Speakers:

Betsabeh Madani Hermann Global Head of ResearchPhilips
Betsabeh Madani Hermann
Global Head of ResearchPhilips
Claire Bloomfield Senior Director, Development & Strategyinsitro
Claire Bloomfield
Senior Director, Development & Strategyinsitro
David C. Rhew, MD Global CMO & VP of HealthcareMicrosoft
David C. Rhew, MD
Global CMO & VP of HealthcareMicrosoft
Jim Swanson Executive VP, Chief Information OfficerJohnson & Johnson
Jim Swanson
Executive VP, Chief Information OfficerJohnson & Johnson
Julien Hobeika PartnerEQT Ventures
Julien Hobeika
PartnerEQT Ventures

About this Session:

An exchange deep into Douglas Adam's The Hitch-Hiker's Guide to the Galaxy, offers a concise summation of much of healthcare's approach to GenAI so far. Marvin The Paranoid Android, a sentient AI with an under utilised brain the size of a planet, is shown a bold vision of his future.\r\nZaphod Beeblebrox: There's a whole new life stretching out in front of you.\r\nMarvin: Oh, not another one.\r\nHealthcare has had more than its fair share of ‘next big things', rendering the collective shrugging of shoulders understandable, from healthcare providers to pharma. The potential pitfalls surrounding GenAI - those of trust, bias-elimination, and accuracy to name a few, are no-go areas in health.\r\nThe benefits are myriad - from routine information gathering to post-treatment monitoring, leveraging population health data sets to better utilising research into new treatments. That GenAI's potential is unfathomable is almost universally recognised. But creating an environment where it can thrive? That requires a level of collaboration, strategy and belief that we've not seen before in healthcare.